Factors Influencing the Decision to Provide General Anesthesia or Moderate Sedation for Treatment Related Procedures in Children with Cancer
|
Children’s Hospital of Philadelphia / Elizabeth Ely, PhD, RN |
Nurse Researcher Grants |
2007 |
Pennsylvania |
Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy in Neuroblastoma |
Children’s Hospital of Philadelphia / Adam Wolpaw, MD/PhD |
Young Investigator Grants |
2019 |
Pennsylvania |
Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition
|
Children’s Hospital of Philadelphia / Yael Mossé, MD |
Reach Grants |
2013 |
Pennsylvania |
Integration of Targeted New Agents with Chemotherapy
|
Children’s Hospital of Philadelphia / Robin Norris, MD |
Young Investigator Grants |
2008 |
Pennsylvania |
Dissecting the Mechanism of Overgrowth and Tumorigenesis in Beckwith-Wiedemann Syndrome |
University of Pennsylvania / Jennifer Kalish, MD, PhD |
Young Investigator Grants |
2013 |
Pennsylvania |
Alex's Lemonade Stand Foundation Center of Excellence in Childhood Cancer Drug Development and Clinical Pharmacology at The Children's Hospital of Philadelphia
|
Children’s Hospital of Philadelphia / Frank Balis, MD - Scholar: Emily Blauel, MD |
Center of Excellence Grants |
2013 |
Pennsylvania |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Hematopoietic Stem And Progenitor Cells Sustain Inflammation And Promote Relapse In The AML Niche |
Children’s Hospital of Philadelphia / Ding-Wen (Roger) Chen, PhD |
Young Investigator Grants |
2021 |
Pennsylvania |
Single-cell Profiling of Early T-cell Precursor Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / David Teachey, MD and Kai Tan, PhD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
Pennsylvania |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification |
Children’s Hospital of Philadelphia / Sharon Diskin, PhD |
Innovation Grants |
2017 |
Pennsylvania |